|Partial Close, 5/2011 ||$1.1M|
|Partial Close, 4/2013 ||$1.55M|
|Venture Round, 9/2013 |
Caldera Pharmaceuticals pioneered high-throughput, label-free XRpro® drug discover technology. XRrpro® allows the screening of millions of compounds per month with no modifications to either the drug candidate or the target protein. XRpro® eliminates costly and error-inducing chemical labels and provides data that more closely approximates in vivo drug behavior.